Columbia University Medical Center New York Presbyterian — New York, New York

Columbia University Medical Center New York Presbyterian is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Columbia University Medical Center New York Presbyterian has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Myeloid Leukemia, Philadelphia Positive, Brain Metastasis, Non-small Cell Lung Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Columbia University Medical Center New York Presbyterian?

Columbia University Medical Center New York Presbyterian has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Columbia University Medical Center New York Presbyterian conducted?

Columbia University Medical Center New York Presbyterian has 2 clinical trials on record, with 1 currently active. Their work covers Myeloid Leukemia, Philadelphia Positive, Brain Metastasis, Non-small Cell Lung Cancer.

Is Columbia University Medical Center New York Presbyterian accredited by Crixeo Health?

Columbia University Medical Center New York Presbyterian has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Columbia University Medical Center New York Presbyterian?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.